Heres a comparison between the two medications: Mounjaros Dual Action: Mounjaro is unique as a dual agonist, targeting both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors
But sometimes plans change or weight goals are reached, so people might want to stop taking GLP-1 RAs
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
Technically balanced in the sense that it exists on a plate together
First-line management includes drinking 1.52 litres of fluids daily, using paracetamol (maximum 4 g daily) or ibuprofen (maximum 1.2 g daily for over-the-counter use) as appropriate, and resting in a quiet environment
Conversely, patients seeking weight loss without gastric side effects or those with contraindications to GLP-1 (e.g., personal or family history of medullary thyroid carcinoma) may explore Contrave or other options with their provider